Market Research Report
Gene Editing Market Size By Application, By Technology, By End-user, Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026
|Gene Editing Market Size By Application, By Technology, By End-user, Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026|
Published: September 30, 2020
Global Market Insights Inc.
Content info: 141 Pages
Delivery time: 2-3 business days
Gene Editing Market Size By Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), By Technology (CRISPR/Cas9, Zinc Finger Nucleases (ZFNs), TALENs), By End-user (Biotech and Pharma Companies, Contract Research Organizations (CROs), Research Institutes), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026.
Gene editing market is likely to record substantial growth in coming years owing to rising incidences of genetic disorders, ongoing development of advanced gene editing technologies, and high adoption of CRISPR technology.
Gene editing or genome editing is group of technologies that gives scientist the capability to change DNA of an organism, including animals, bacteria, and plants. Editing DNA could further lead to changes in physical traits such as disease risk, and eye color. Scientist generally utilize different technologies to do this. These technologies, further allow the genetic material to be altered, removed or added at a specific place in the genome.
The gene editing market is bifurcated in terms of application, technology, end-user, and regional landscape.
With respect to application, the gene editing market is classified into plant genetic engineering, animal genetic engineering, cell line engineering, and others. Among these, cell line engineering segment will witness more than 14.5% CAGR over the forecast time period. Extensive applications of cell line engineering are likely to augment the segment growth.
The current technology in gene editing nucleases such as TALENs (transcription activator-like effector nucleases), ZFNs (zinc finger nucleases), and CRISPR/Cas systems have further made cell engineering relatively cheaper and easy fostering revenue outlook.
Based on technology, the gene editing market is categorized into TALENs, ZFNs, CRISPR/Cas9, and others. In 2019, the CRISPR/Cas9 segment held around 46.5% market share with estimates expecting it to follow a lucrative growth trend over the coming years. The growth is ascribed to rising preference towards CRISPR technology owing to several segmental advantages.
CRISPR-Cas9 is one of the most efficient and inexpensive system used for genome editing. The functions of CRISPR along with other related genes is important in adaptive immunity in selective archaea and bacteria. It further enables organism to respond to and remove any invading genetic material.
In terms of end-user, the overall gene editing market is segmented into research institutes, contract research organizations (CROs), and biotech & pharma companies. Among these, biotech & pharma companies segment is slated to witness remarkable growth over the coming years. In 2019, the segment accounted for a market valuation of more than $1.5 billion. The growth is ascribed to the increasing focus of biopharmaceutical companies on developing advanced gene editing technologies.
From a regional frame of reference, Latin America gene editing market will witness substantial growth over the coming years. The region in 2019, accounted for over 11% market share, attributable to rising incidences of genetic disorders across several Latin American countries.